We are live on ! Find out more
OSIR

Osiris Therapeutics, Inc. Common Stock
OSIR

Delisted

OSIR was delisted on the 16th of April, 2019.

Back to rankings

1 hedge funds and large institutions have $1K invested in Osiris Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% less funds holding

Funds holding: 57 → 1 (-56)

100% less capital invested

Capital invested by funds: $130M → $1K (-$130M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 56

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-56
Holders Change %
-98.25%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
56
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AAM
Alpine Associates Management
Florida
-$23.4M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$15.6M
3
GF
Gabelli Funds
New York
-$11M
4
Renaissance Technologies
Renaissance Technologies
New York
-$7.54M
5
Millennium Management
Millennium Management
New York
-$6.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMP
26
Polar Asset Management Partners
Ontario, Canada
– -$1.43M -75,000 Closed
JG
27
Jefferies Group
New York
– -$1.3M -68,678 Closed
Acadian Asset Management
28
Acadian Asset Management
Massachusetts
– -$1.11M -58,599 Closed
JP Morgan Chase
29
JP Morgan Chase
New York
– -$1.08M -56,807 Closed
DAM
30
Deltec Asset Management
New York
– -$950K -50,000 Closed
GI
31
GAMCO Investors
Connecticut
– -$914K -48,099 Closed
OSAM
32
O'Shaughnessy Asset Management
Connecticut
– -$839K -44,348 Closed
Citigroup
33
Citigroup
New York
– -$788K -41,476 Closed
Capstone Investment Advisors
34
Capstone Investment Advisors
New York
– -$764K -40,196 Closed
ECM
35
ExodusPoint Capital Management
New York
– -$701K -36,904 Closed
TEE
36
Tibra Equities Europe
United Kingdom
– -$655K -34,458 Closed
CLOS
37
Compagnie Lombard Odier SCmA
Switzerland
– -$570K -29,992 Closed
Squarepoint
38
Squarepoint
New York
– -$563K -29,620 Closed
BCM
39
BlueCrest Capital Management
Jersey
– -$447K -23,530 Closed
Wells Fargo
40
Wells Fargo
California
– -$401K -21,110 Closed
HKAM
41
Horizon Kinetics Asset Management
New York
– -$361K -19,000 Closed
AG
42
Algert Global
California
– -$281K -14,774 Closed
TI
43
Trexquant Investment
Connecticut
– -$256K -13,486 Closed
VF
44
Virtu Financial
New York
– -$247K -13,012 Closed
Verition Fund Management
45
Verition Fund Management
Connecticut
– -$236K -12,440 Closed
State Street
46
State Street
Massachusetts
– -$220K -11,600 Closed
PCM
47
Prelude Capital Management
New York
– -$177K -9,311 Closed
UBS Group
48
UBS Group
Switzerland
– -$146K -7,699 Closed
HR
49
Howe & Rusling
New York
– -$79K -4,150 Closed
AG
50
Advisor Group
Arizona
– -$72K -3,775 Closed
1
2
3

OSIR Hedge Fund Activity: Q2 2019 in Review

1 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q2 2019, worth a combined $1K — down 100% from $130M a quarter earlier.

Sellers outnumbered buyers: 56 funds closed out of OSIR and 0 opened new positions — a net loss of 56 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Alpine Associates Management, exiting entirely with an estimated $23.4M sold.

  • 1 institutional investor held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q2 2019, down from 57 in Q1 2019.
  • Funds reported $1K of Osiris Therapeutics, Inc. Common Stock stock for Q2 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q2 2019 and 56 closed out, a net change of -56 holders.
  • The largest Osiris Therapeutics, Inc. Common Stock seller in Q2 2019 was Alpine Associates Management, an estimated $23.4M sold.

Based on aggregated 13F filings for Q2 2019.